05/06/2024 6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 3:06 PM | Stoke Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024 3:08 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024 3:11 PM | Stoke Therapeutics (Filer)
| Form ARS | |
04/18/2024 3:16 PM | Blue Horizon Enterprise Ltd (Reporting) Ezbon International Ltd (Reporting) Montrago Trustees Ltd (Reporting) Skorpios Trust (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 3:18 PM | Skorpios Trust (Filed by) Stoke Therapeutics (Subject)
| Form SC 13D/A | |
04/17/2024 3:17 PM | Ezbon International Ltd (Reporting) Stoke Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/11/2024 3:06 PM | Stoke Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024 3:19 PM | Nash Huw M. (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:36 PM | Nash Huw M. (Reporting) Stoke Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024 4:20 PM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:47 PM | Stoke Therapeutics (Filer)
| Form 424B5 | |
03/25/2024 3:03 PM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 3:07 PM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 3:07 PM | Stoke Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/19/2024 7:29 PM | Allan Jonathan (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:30 PM | Kaye Edward M. MD (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:31 PM | Nash Huw M. (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:34 PM | Stoke Therapeutics (Issuer) Ticho Barry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:36 PM | Stoke Therapeutics (Issuer) Tulipano Stephen J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 9:36 AM | Cowen Financial Products LLC (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G | |
02/26/2024 9:38 AM | Cowen Financial Products LLC (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/15/2024 3:17 PM | Stoke Therapeutics (Issuer) TZIANABOS ARTHUR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:20 AM | Lynx1 Capital Management LP (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 6:44 AM | RTW INVESTMENTS, LP (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 1:51 PM | MORGAN STANLEY (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024 3:32 PM | Stoke Therapeutics (Issuer) Ticho Barry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:49 PM | Stoke Therapeutics (Subject) Ticho Barry (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:09 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:15 PM | Kaye Edward M. MD (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:17 PM | Nash Huw M. (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:18 PM | Stoke Therapeutics (Issuer) Ticho Barry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:20 PM | Stoke Therapeutics (Issuer) Tulipano Stephen J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 8:04 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/17/2023 3:37 PM | Stoke Therapeutics (Subject)
| Form SC TO-I/A | |
11/07/2023 6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 8:01 AM | Stoke Therapeutics (Subject)
| Form SC TO-I | |
10/26/2023 4:00 PM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 3:44 PM | SMITH IAN F (Reporting) Stoke Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/20/2023 3:48 PM | SMITH IAN F (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Shocking $16T Elon Musk Crypto Leak (Ad) There’s all kinds of “signals” to follow when investing in cryptos.
But there’s one signal you should pay attention to above all others: Venture capital firms.
You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… |
09/20/2023 3:37 PM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:05 PM | Stoke Therapeutics (Filer)
| Form PRE 14A | |
09/08/2023 3:15 PM | Kaye Edward M. MD (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/25/2023 6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 4:20 PM | Stoke Therapeutics (Issuer) Ticho Barry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:45 PM | Allan Jonathan (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:18 PM | Allan Jonathan (Reporting) Stoke Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 5:24 PM | LEVIN ARTHUR A (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:25 PM | Menzel Garry E (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:26 PM | Smith Julie (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:26 PM | Stoke Therapeutics (Issuer) TZIANABOS ARTHUR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:22 PM | Burstein Jennifer (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:23 PM | Harrison Seth Loring (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:24 PM | Krainer Adrian R. (Reporting) Stoke Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 6:31 PM | Stoke Therapeutics (Issuer) Ticho Barry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:15 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |